Acute Lymphoblastic Leukaemia

Genetic changes - relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia; immunophenotypic classification of acute lymphoblastic leukaemia; morphology and cytochemistry of acute lymphoblastic leukaemia; advances in the therapy for childhood non-B lymphoblastic leukaemia; therapy of B-acute lymphoblastic leukaemia in childhood - the BFM experience; therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma - experience with the LMB protocols of the SFOP (French Pediatric Oncology Society) in children and adults; bone marrow transplantation for acute lymphoblastic leukaemia; autologous bone marrow transplantation in acute lymphoblastic leukaemia; IL2 and gene therapy in the management of acute lymphoblastic leukaemia; central nervous system directed therapy in acute lymphoblastic leukaemia; long-term sequelae of therapy for childhood acute lymphoblastic leukaemia.